Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer.

Morrow M, Jagsi R, McLeod MC, Shumway D, Katz SJ.

JAMA Oncol. 2018 Jul 12. doi: 10.1001/jamaoncol.2018.1908. [Epub ahead of print]

PMID:
30003237
2.

Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer.

Katz SJ, Bondarenko I, Ward KC, Hamilton AS, Morrow M, Kurian AW, Hofer TP.

JAMA Surg. 2018 Jul 3. doi: 10.1001/jamasurg.2018.2001. [Epub ahead of print]

PMID:
29971344
3.

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.

Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, Li Y, Hawley ST, Morrow M, Jagsi R, Katz SJ.

JAMA Oncol. 2018 May 10. doi: 10.1001/jamaoncol.2018.0644. [Epub ahead of print]

PMID:
29801090
4.

Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer.

Shumway DA, Griffith KA, Hawley ST, Wallner LP, Ward KC, Hamilton AS, Morrow M, Katz SJ, Jagsi R.

Cancer. 2018 Jul 1;124(13):2714-2723. doi: 10.1002/cncr.31378. Epub 2018 Apr 18.

PMID:
29669187
5.

Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.

Katz SJ, Ward KC, Hamilton AS, Mcleod MC, Wallner LP, Morrow M, Jagsi R, Hawley ST, Kurian AW.

J Clin Oncol. 2018 Apr 20;36(12):1218-1224. doi: 10.1200/JCO.2017.76.2369. Epub 2018 Mar 12.

PMID:
29528794
6.

Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered.

Katz SJ, Jagsi R, Morrow M.

JAMA. 2018 Mar 20;319(11):1091-1092. doi: 10.1001/jama.2018.0018. No abstract available.

PMID:
29470568
7.

Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ.

Shumway DA, McLeod CM, Morrow M, Li Y, Kurian AW, Sabolch A, Hamilton AS, Ward KC, Katz SJ, Hawley ST, Jagsi R.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1237-1245. doi: 10.1016/j.ijrobp.2018.01.020. Epub 2018 Jan 9.

PMID:
29439886
8.

Trend Analysis on Reoperation After Lumpectomy for Breast Cancer-Reply.

Morrow M, Abrahamse P, Katz SJ.

JAMA Oncol. 2018 May 1;4(5):747. doi: 10.1001/jamaoncol.2017.5261. No abstract available.

PMID:
29423506
9.

Cognitive Bridging: Using Strategic Communication To Connect Abstract Goals With The Means To Achieve Them.

Katz SJ, Byrne S.

Health Commun. 2018 Jan 29:1-16. doi: 10.1080/10410236.2018.1428848. [Epub ahead of print]

PMID:
29377726
10.

Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial.

Hawley ST, Li Y, An LC, Resnicow K, Janz NK, Sabel MS, Ward KC, Fagerlin A, Morrow M, Jagsi R, Hofer TP, Katz SJ.

J Clin Oncol. 2018 Mar 1;36(7):659-666. doi: 10.1200/JCO.2017.74.8442. Epub 2018 Jan 24.

PMID:
29364772
11.

Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.

Kurian AW, Bondarenko I, Jagsi R, Friese CR, McLeod MC, Hawley ST, Hamilton AS, Ward KC, Hofer TP, Katz SJ.

J Natl Cancer Inst. 2018 May 1;110(5):493-500. doi: 10.1093/jnci/djx239.

PMID:
29237009
12.

Ask the rheumatologist online: a qualitative analysis of a web-based service.

Katz SJ.

Clin Rheumatol. 2018 Feb;37(2):539-541. doi: 10.1007/s10067-017-3924-y. Epub 2017 Nov 25.

PMID:
29177983
13.

Study protocol: A Randomized Controlled Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool (iCanDecide).

Hawley ST, Li Y, Jeanpierre LA, Goodell S, Jagsi R, Ward KC, Sabel MS, Katz SJ.

Contemp Clin Trials Commun. 2017 Mar;5:123-132. doi: 10.1016/j.conctc.2017.02.001. Epub 2017 Feb 3.

14.

Reply to K. Lisy et al.

Wallner LP, Katz SJ, Hawley ST.

J Clin Oncol. 2017 Dec 1;35(34):3891. doi: 10.1200/JCO.2017.75.8615. Epub 2017 Oct 12. No abstract available.

PMID:
29023214
15.

Treatment decisions and employment of breast cancer patients: Results of a population-based survey.

Jagsi R, Abrahamse PH, Lee KL, Wallner LP, Janz NK, Hamilton AS, Ward KC, Morrow M, Kurian AW, Friese CR, Hawley ST, Katz SJ.

Cancer. 2017 Dec 15;123(24):4791-4799. doi: 10.1002/cncr.30959. Epub 2017 Oct 9.

PMID:
28990155
16.

Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.

Katz SJ, Hawley ST, Hamilton AS, Ward KC, Morrow M, Jagsi R, Hofer TP.

JAMA Surg. 2018 Jan 1;153(1):29-36. doi: 10.1001/jamasurg.2017.3415.

17.

What Factors Influence Women's Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment?

Lee KL, Janz NK, Zikmund-Fisher BJ, Jagsi R, Wallner LP, Kurian AW, Katz SJ, Abrahamse P, Hawley ST.

Med Decis Making. 2018 Jan;38(1):95-106. doi: 10.1177/0272989X17724441. Epub 2017 Aug 17.

PMID:
28814131
18.

The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients.

Hawley ST, Griffith KA, Hamilton AS, Ward KC, Morrow M, Janz NK, Katz SJ, Jagsi R.

Cancer. 2017 Dec 1;123(23):4547-4555. doi: 10.1002/cncr.30924. Epub 2017 Aug 15.

PMID:
28810062
19.

Patient Preferences for Primary Care Provider Roles in Breast Cancer Survivorship Care.

Wallner LP, Li Y, Furgal AKC, Friese CR, Hamilton AS, Ward KC, Jagsi R, Katz SJ, Hawley ST.

J Clin Oncol. 2017 Sep 1;35(25):2942-2948. doi: 10.1200/JCO.2017.73.1307. Epub 2017 Jul 12.

PMID:
28700276
20.

Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?

Katz SJ, Hawley ST, Bondarenko I, Jagsi R, Ward KC, Hofer TP, Kurian AW.

Breast Cancer Res Treat. 2017 Oct;165(3):751-756. doi: 10.1007/s10549-017-4377-3. Epub 2017 Jul 8.

PMID:
28689364
21.

Decision-support networks of women newly diagnosed with breast cancer.

Wallner LP, Li Y, McLeod MC, Hamilton AS, Ward KC, Veenstra CM, An LC, Janz NK, Katz SJ, Hawley ST.

Cancer. 2017 Oct 15;123(20):3895-3903. doi: 10.1002/cncr.30848. Epub 2017 Jun 22.

PMID:
28640360
22.

Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management.

Morrow M, Abrahamse P, Hofer TP, Ward KC, Hamilton AS, Kurian AW, Katz SJ, Jagsi R.

JAMA Oncol. 2017 Oct 1;3(10):1352-1357. doi: 10.1001/jamaoncol.2017.0774.

PMID:
28586788
23.

Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey.

Schultz M, Keeling SO, Katz SJ, Maksymowych WP, Eurich DT, Hall JJ.

Clin Rheumatol. 2017 Jul;36(7):1471-1478. doi: 10.1007/s10067-017-3687-5. Epub 2017 May 27.

PMID:
28550389
24.

Involvement of Primary Care Physicians in the Decision Making and Care of Patients With Breast Cancer.

Wallner LP, Abrahamse P, Uppal JK, Friese CR, Hamilton AS, Ward KC, Katz SJ, Hawley ST.

J Clin Oncol. 2016 Nov 20;34(33):3969-3975. doi: 10.1200/JCO.2016.67.8896. Epub 2016 Oct 31.

25.

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.

Kurian AW, Li Y, Hamilton AS, Ward KC, Hawley ST, Morrow M, McLeod MC, Jagsi R, Katz SJ.

J Clin Oncol. 2017 Jul 10;35(20):2232-2239. doi: 10.1200/JCO.2016.71.6480. Epub 2017 Apr 12.

26.

Treatment experiences of Latinas after diagnosis of breast cancer.

Katz SJ, Wallner LP, Abrahamse PH, Janz NK, Martinez KA, Shumway DA, Hamilton AS, Ward KC, Resnicow KA, Hawley ST.

Cancer. 2017 Aug 15;123(16):3022-3030. doi: 10.1002/cncr.30702. Epub 2017 Apr 11.

PMID:
28398629
27.

Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.

Katz SJ, Janz NK, Abrahamse P, Wallner LP, Hawley ST, An LC, Ward KC, Hamilton AS, Morrow M, Jagsi R.

JAMA Surg. 2017 Jul 1;152(7):658-664. doi: 10.1001/jamasurg.2017.0458.

28.

Surgeon Attitudes and Use of MRI in Patients Newly Diagnosed with Breast Cancer.

Morrow M, Hawley ST, McLeod MC, Hamilton AS, Ward KC, Katz SJ, Jagsi R.

Ann Surg Oncol. 2017 Jul;24(7):1889-1896. doi: 10.1245/s10434-017-5840-4. Epub 2017 Mar 22.

29.

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .

Kurian AW, Griffith KA, Hamilton AS, Ward KC, Morrow M, Katz SJ, Jagsi R.

JAMA. 2017 Feb 7;317(5):531-534. doi: 10.1001/jama.2016.16918. No abstract available.

30.

Treatment-associated toxicities reported by patients with early-stage invasive breast cancer.

Friese CR, Harrison JM, Janz NK, Jagsi R, Morrow M, Li Y, Hamilton AS, Ward KC, Kurian AW, Katz SJ, Hofer TP.

Cancer. 2017 Jun 1;123(11):1925-1934. doi: 10.1002/cncr.30547. Epub 2017 Jan 24.

31.

Self-reported use of natural health products among rheumatology patients: A cross-sectional survey.

Hall JJ, Dissanayake TD, Lau D, Katz SJ.

Musculoskeletal Care. 2017 Dec;15(4):345-349. doi: 10.1002/msc.1178. Epub 2017 Jan 4.

PMID:
28052563
32.

Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences.

Kurian AW, Friese CR, Bondarenko I, Jagsi R, Li Y, Hamilton AS, Ward KC, Katz SJ.

JAMA Oncol. 2017 Mar 1;3(3):391-397. doi: 10.1001/jamaoncol.2016.5652.

33.

The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients.

Li Y, Kurian AW, Bondarenko I, Taylor JMG, Jagsi R, Ward KC, Hamilton AS, Katz SJ, Hofer TP.

Breast Cancer Res Treat. 2017 Feb;161(3):587-595. doi: 10.1007/s10549-016-4086-3. Epub 2016 Dec 23.

34.

Recurrence risk perception and quality of life following treatment of breast cancer.

Hawley ST, Janz NK, Griffith KA, Jagsi R, Friese CR, Kurian AW, Hamilton AS, Ward KC, Morrow M, Wallner LP, Katz SJ.

Breast Cancer Res Treat. 2017 Feb;161(3):557-565. doi: 10.1007/s10549-016-4082-7. Epub 2016 Dec 21.

35.

Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.

Jagsi R, Hawley ST, Griffith KA, Janz NK, Kurian AW, Ward KC, Hamilton AS, Morrow M, Katz SJ.

JAMA Surg. 2017 Mar 1;152(3):274-282. doi: 10.1001/jamasurg.2016.4749.

36.

The impact of doctor-patient communication on patients' perceptions of their risk of breast cancer recurrence.

Janz NK, Li Y, Zikmund-Fisher BJ, Jagsi R, Kurian AW, An LC, McLeod MC, Lee KL, Katz SJ, Hawley ST.

Breast Cancer Res Treat. 2017 Feb;161(3):525-535. doi: 10.1007/s10549-016-4076-5. Epub 2016 Dec 9.

37.

Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample.

Griggs JJ, Hamilton AS, Schwartz KL, Zhao W, Abrahamse PH, Thomas DG, Jorns JM, Jewell R, Saber ME, Haque R, Katz SJ.

Breast Cancer Res Treat. 2017 Jan;161(2):375-384. doi: 10.1007/s10549-016-4061-z. Epub 2016 Nov 29.

38.

Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer.

Friese CR, Li Y, Bondarenko I, Hofer TP, Ward KC, Hamilton AS, Deapen D, Kurian AW, Katz SJ.

Cancer. 2017 Jan 1;123(1):43-51. doi: 10.1002/cncr.30324. Epub 2016 Oct 24.

39.

Patient Satisfaction with Pharmacist-Led Collaborative Follow-Up Care in an Ambulatory Rheumatology Clinic.

Hall JJ, Katz SJ, Cor MK.

Musculoskeletal Care. 2017 Sep;15(3):186-195. doi: 10.1002/msc.1160. Epub 2016 Sep 30.

PMID:
27686752
40.

Use of Online Communication by Patients With Newly Diagnosed Breast Cancer During the Treatment Decision Process.

Wallner LP, Martinez KA, Li Y, Jagsi R, Janz NK, Katz SJ, Hawley ST.

JAMA Oncol. 2016 Dec 1;2(12):1654-1656. doi: 10.1001/jamaoncol.2016.2070. No abstract available.

41.

Does physician communication style impact patient report of decision quality for breast cancer treatment?

Martinez KA, Resnicow K, Williams GC, Silva M, Abrahamse P, Shumway DA, Wallner LP, Katz SJ, Hawley ST.

Patient Educ Couns. 2016 Dec;99(12):1947-1954. doi: 10.1016/j.pec.2016.06.025. Epub 2016 Jun 22.

42.

Addressing Overtreatment in DCIS: What Should Physicians Do Now?

Morrow M, Katz SJ.

J Natl Cancer Inst. 2015 Sep 30;107(12):djv290. doi: 10.1093/jnci/djv290. Print 2015 Dec. No abstract available.

PMID:
26424780
43.

Reply to S.M. Sorscher and A.B. Hafeez Bhatti.

Jagsi R, Griffith KA, Kurian AW, Morrow M, Hamilton AS, Graff JJ, Katz SJ, Hawley ST.

J Clin Oncol. 2015 Dec 10;33(35):4233. doi: 10.1200/JCO.2015.63.5524. Epub 2015 Sep 14. No abstract available.

PMID:
26371137
44.

Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon.

Angelos P, Bedrosian I, Euhus DM, Herrmann VM, Katz SJ, Pusic A.

Ann Surg Oncol. 2015 Oct;22(10):3208-12. doi: 10.1245/s10434-015-4758-y. Epub 2015 Aug 11.

45.

Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations.

Katz SJ, Kurian AW, Morrow M.

JAMA. 2015 Sep 8;314(10):997-8. doi: 10.1001/jama.2015.8088. No abstract available.

PMID:
26203642
46.

Cancer Care Delivery Research and the National Cancer Institute SEER Program: Challenges and Opportunities.

Katz SJ.

JAMA Oncol. 2015 Aug;1(5):677-8. doi: 10.1001/jamaoncol.2015.0764. No abstract available.

PMID:
26181240
47.

Evaluating a Decision Aid for Improving Decision Making in Patients with Early-stage Breast Cancer.

Hawley ST, Newman L, Griggs JJ, Kosir MA, Katz SJ.

Patient. 2016 Apr;9(2):161-9. doi: 10.1007/s40271-015-0135-y.

48.

Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.

Jagsi R, Griffith KA, Kurian AW, Morrow M, Hamilton AS, Graff JJ, Katz SJ, Hawley ST.

J Clin Oncol. 2015 May 10;33(14):1584-91. doi: 10.1200/JCO.2014.58.5885. Epub 2015 Apr 6.

49.

A qualitative analysis of methotrexate self-injection education videos on YouTube.

Rittberg R, Dissanayake T, Katz SJ.

Clin Rheumatol. 2016 May;35(5):1329-33. doi: 10.1007/s10067-015-2910-5. Epub 2015 Mar 6.

PMID:
25739847
50.

Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making.

Morrow M, Li Y, Alderman AK, Jagsi R, Hamilton AS, Graff JJ, Hawley ST, Katz SJ.

JAMA Surg. 2014 Oct;149(10):1015-21. doi: 10.1001/jamasurg.2014.548.

Supplemental Content

Support Center